Lennar Corporation
Lennar Corporation (LEN-B) Stock Competitors & Peer Comparison
See (LEN-B) competitors and their performances in Stock Market.
Peer Comparison Table: Residential Construction Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LEN-B | $89.74 | +2.49% | 23.1B | 11.24 | $7.98 | +2.09% |
| DHI | $140.49 | +1.04% | 40.9B | 12.78 | $10.99 | +1.21% |
| LEN | $94.96 | +2.62% | 24.5B | 11.91 | $7.98 | +2.09% |
| PHM | $119.19 | -1.05% | 22.9B | 10.72 | $11.12 | +0.77% |
| NVR | $6,466.56 | +0.43% | 18.4B | 14.80 | $436.84 | N/A |
| TOL | $136.69 | -0.96% | 13B | 9.82 | $13.92 | +0.73% |
| IBP | $284.69 | +4.62% | 7.7B | 29.33 | $9.71 | +1.90% |
| TMHC | $59.20 | +0.58% | 5.7B | 7.62 | $7.77 | N/A |
| MDC | $62.98 | +0.05% | 4.7B | 11.91 | $5.29 | +3.41% |
| MTH | $63.08 | +0.48% | 4.4B | 9.93 | $6.35 | +2.72% |
Stock Comparison
LEN-B vs DHI Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, DHI has a market cap of 40.9B. Regarding current trading prices, LEN-B is priced at $89.74, while DHI trades at $140.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas DHI's P/E ratio is 12.78. In terms of profitability, LEN-B's ROE is +0.12%, compared to DHI's ROE of +0.14%. Regarding short-term risk, LEN-B is more volatile compared to DHI. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check DHI's competition here
LEN-B vs LEN Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, LEN has a market cap of 24.5B. Regarding current trading prices, LEN-B is priced at $89.74, while LEN trades at $94.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas LEN's P/E ratio is 11.91. In terms of profitability, LEN-B's ROE is +0.12%, compared to LEN's ROE of +0.12%. Regarding short-term risk, LEN-B is more volatile compared to LEN. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check LEN's competition here
LEN-B vs PHM Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, PHM has a market cap of 22.9B. Regarding current trading prices, LEN-B is priced at $89.74, while PHM trades at $119.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas PHM's P/E ratio is 10.72. In terms of profitability, LEN-B's ROE is +0.12%, compared to PHM's ROE of +0.18%. Regarding short-term risk, LEN-B is more volatile compared to PHM. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check PHM's competition here
LEN-B vs NVR Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, NVR has a market cap of 18.4B. Regarding current trading prices, LEN-B is priced at $89.74, while NVR trades at $6,466.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas NVR's P/E ratio is 14.80. In terms of profitability, LEN-B's ROE is +0.12%, compared to NVR's ROE of +0.34%. Regarding short-term risk, LEN-B is more volatile compared to NVR. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check NVR's competition here
LEN-B vs TOL Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, TOL has a market cap of 13B. Regarding current trading prices, LEN-B is priced at $89.74, while TOL trades at $136.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas TOL's P/E ratio is 9.82. In terms of profitability, LEN-B's ROE is +0.12%, compared to TOL's ROE of +0.17%. Regarding short-term risk, LEN-B is more volatile compared to TOL. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check TOL's competition here
LEN-B vs IBP Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, IBP has a market cap of 7.7B. Regarding current trading prices, LEN-B is priced at $89.74, while IBP trades at $284.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas IBP's P/E ratio is 29.33. In terms of profitability, LEN-B's ROE is +0.12%, compared to IBP's ROE of +0.39%. Regarding short-term risk, LEN-B is less volatile compared to IBP. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check IBP's competition here
LEN-B vs TMHC Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, TMHC has a market cap of 5.7B. Regarding current trading prices, LEN-B is priced at $89.74, while TMHC trades at $59.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas TMHC's P/E ratio is 7.62. In terms of profitability, LEN-B's ROE is +0.12%, compared to TMHC's ROE of +0.13%. Regarding short-term risk, LEN-B is more volatile compared to TMHC. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check TMHC's competition here
LEN-B vs MDC Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, MDC has a market cap of 4.7B. Regarding current trading prices, LEN-B is priced at $89.74, while MDC trades at $62.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas MDC's P/E ratio is 11.91. In terms of profitability, LEN-B's ROE is +0.12%, compared to MDC's ROE of +0.02%. Regarding short-term risk, LEN-B is more volatile compared to MDC. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check MDC's competition here
LEN-B vs MTH Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, MTH has a market cap of 4.4B. Regarding current trading prices, LEN-B is priced at $89.74, while MTH trades at $63.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas MTH's P/E ratio is 9.93. In terms of profitability, LEN-B's ROE is +0.12%, compared to MTH's ROE of +0.09%. Regarding short-term risk, LEN-B is more volatile compared to MTH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check MTH's competition here
LEN-B vs SKY Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, SKY has a market cap of 4.3B. Regarding current trading prices, LEN-B is priced at $89.74, while SKY trades at $77.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas SKY's P/E ratio is 20.66. In terms of profitability, LEN-B's ROE is +0.12%, compared to SKY's ROE of +0.14%. Regarding short-term risk, LEN-B is more volatile compared to SKY. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check SKY's competition here
LEN-B vs TPH Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, TPH has a market cap of 4B. Regarding current trading prices, LEN-B is priced at $89.74, while TPH trades at $46.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas TPH's P/E ratio is 17.01. In terms of profitability, LEN-B's ROE is +0.12%, compared to TPH's ROE of +0.07%. Regarding short-term risk, LEN-B is more volatile compared to TPH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check TPH's competition here
LEN-B vs CVCO Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, CVCO has a market cap of 3.9B. Regarding current trading prices, LEN-B is priced at $89.74, while CVCO trades at $496.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas CVCO's P/E ratio is 21.58. In terms of profitability, LEN-B's ROE is +0.12%, compared to CVCO's ROE of +0.17%. Regarding short-term risk, LEN-B is more volatile compared to CVCO. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check CVCO's competition here
LEN-B vs MHO Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, MHO has a market cap of 3.4B. Regarding current trading prices, LEN-B is priced at $89.74, while MHO trades at $128.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas MHO's P/E ratio is 8.74. In terms of profitability, LEN-B's ROE is +0.12%, compared to MHO's ROE of +0.13%. Regarding short-term risk, LEN-B is more volatile compared to MHO. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check MHO's competition here
LEN-B vs KBH Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, KBH has a market cap of 3.3B. Regarding current trading prices, LEN-B is priced at $89.74, while KBH trades at $52.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas KBH's P/E ratio is 8.61. In terms of profitability, LEN-B's ROE is +0.12%, compared to KBH's ROE of +0.11%. Regarding short-term risk, LEN-B is more volatile compared to KBH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check KBH's competition here
LEN-B vs HOVNP Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, HOVNP has a market cap of 3.1B. Regarding current trading prices, LEN-B is priced at $89.74, while HOVNP trades at $21.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas HOVNP's P/E ratio is -8.64. In terms of profitability, LEN-B's ROE is +0.12%, compared to HOVNP's ROE of +0.07%. Regarding short-term risk, LEN-B is more volatile compared to HOVNP. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check HOVNP's competition here
LEN-B vs GRBK Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, GRBK has a market cap of 2.8B. Regarding current trading prices, LEN-B is priced at $89.74, while GRBK trades at $65.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas GRBK's P/E ratio is 9.20. In terms of profitability, LEN-B's ROE is +0.12%, compared to GRBK's ROE of +0.18%. Regarding short-term risk, LEN-B is more volatile compared to GRBK. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check GRBK's competition here
LEN-B vs CCS Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, CCS has a market cap of 1.7B. Regarding current trading prices, LEN-B is priced at $89.74, while CCS trades at $57.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas CCS's P/E ratio is 11.87. In terms of profitability, LEN-B's ROE is +0.12%, compared to CCS's ROE of +0.06%. Regarding short-term risk, LEN-B is more volatile compared to CCS. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check CCS's competition here
LEN-B vs DFH Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, DFH has a market cap of 1.4B. Regarding current trading prices, LEN-B is priced at $89.74, while DFH trades at $15.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas DFH's P/E ratio is 7.25. In terms of profitability, LEN-B's ROE is +0.12%, compared to DFH's ROE of +0.14%. Regarding short-term risk, LEN-B is less volatile compared to DFH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check DFH's competition here
LEN-B vs LGIH Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, LGIH has a market cap of 954.2M. Regarding current trading prices, LEN-B is priced at $89.74, while LGIH trades at $41.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas LGIH's P/E ratio is 13.22. In terms of profitability, LEN-B's ROE is +0.12%, compared to LGIH's ROE of +0.04%. Regarding short-term risk, LEN-B is more volatile compared to LGIH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check LGIH's competition here
LEN-B vs GRBK-PA Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, GRBK-PA has a market cap of 938M. Regarding current trading prices, LEN-B is priced at $89.74, while GRBK-PA trades at $21.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas GRBK-PA's P/E ratio is 4.86. In terms of profitability, LEN-B's ROE is +0.12%, compared to GRBK-PA's ROE of +0.18%. Regarding short-term risk, LEN-B is more volatile compared to GRBK-PA. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check GRBK-PA's competition here
LEN-B vs BZH Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, BZH has a market cap of 614.4M. Regarding current trading prices, LEN-B is priced at $89.74, while BZH trades at $20.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas BZH's P/E ratio is 71.79. In terms of profitability, LEN-B's ROE is +0.12%, compared to BZH's ROE of +0.01%. Regarding short-term risk, LEN-B is more volatile compared to BZH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check BZH's competition here
LEN-B vs HOV Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, HOV has a market cap of 548.9M. Regarding current trading prices, LEN-B is priced at $89.74, while HOV trades at $106.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas HOV's P/E ratio is 16.46. In terms of profitability, LEN-B's ROE is +0.12%, compared to HOV's ROE of +0.07%. Regarding short-term risk, LEN-B is more volatile compared to HOV. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check HOV's competition here
LEN-B vs LEGH Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, LEGH has a market cap of 448.5M. Regarding current trading prices, LEN-B is priced at $89.74, while LEGH trades at $18.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas LEGH's P/E ratio is 9.64. In terms of profitability, LEN-B's ROE is +0.12%, compared to LEGH's ROE of +0.09%. Regarding short-term risk, LEN-B is less volatile compared to LEGH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check LEGH's competition here
LEN-B vs SIC Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, SIC has a market cap of 376M. Regarding current trading prices, LEN-B is priced at $89.74, while SIC trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas SIC's P/E ratio is 7.11. In terms of profitability, LEN-B's ROE is +0.12%, compared to SIC's ROE of -0.06%. Regarding short-term risk, LEN-B is more volatile compared to SIC. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check SIC's competition here
LEN-B vs UHG Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, UHG has a market cap of 68.2M. Regarding current trading prices, LEN-B is priced at $89.74, while UHG trades at $1.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas UHG's P/E ratio is -3.52. In terms of profitability, LEN-B's ROE is +0.12%, compared to UHG's ROE of -0.23%. Regarding short-term risk, LEN-B is more volatile compared to UHG. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check UHG's competition here
LEN-B vs SPHL Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, SPHL has a market cap of 5M. Regarding current trading prices, LEN-B is priced at $89.74, while SPHL trades at $3.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas SPHL's P/E ratio is -3.12. In terms of profitability, LEN-B's ROE is +0.12%, compared to SPHL's ROE of -0.23%. Regarding short-term risk, LEN-B is less volatile compared to SPHL. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check SPHL's competition here
LEN-B vs NWHM Comparison March 2026
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 23.1B. In comparison, NWHM has a market cap of 0. Regarding current trading prices, LEN-B is priced at $89.74, while NWHM trades at $8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 11.24, whereas NWHM's P/E ratio is N/A. In terms of profitability, LEN-B's ROE is +0.12%, compared to NWHM's ROE of -0.15%. Regarding short-term risk, LEN-B is more volatile compared to NWHM. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check NWHM's competition here